The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C†
Open accessAbstract
The advent of specific antiviral therapy for chronic hepatitis C has increased the importance of establishing the correct etiology of chronic hepatitis in patients, especially because interferon alfa (IFN-α) has been reported to exacerbate autoimmune hepatitis (AIH), whereas corticosteroids increase viral replication in chronic hepatitis C. In our medical center, we have treated many patients with apparent chronic hepatitis C and serological or clinical evidence of autoimmunity. Our aim was to estimate the prevalence of this association and to learn whether demographic or clinical features distinguished between patients with or without autoimmune markers. We performed a retrospective review of the records of 244 unselected patients seen at the Clinics and Hospital of the University of Massachusetts between May 1991 and November 1993, who had elevated serum aminotransferases. One hundred seventeen patients had chronic hepatitis C defined by elevations of serum alanine transaminase (ALT) for at least 6 months, positive serum antibodies to hepatitis C virus (HCV; second-generation enzyme immunoassay [EIA2] or recombinant immunoblot assay [RIBA]), and absence of hepatitis B surface antigen in the serum. Records were reviewed for results of autoimmune markers in sera, including anti-nuclear antibodies (ANAs), anti—smooth muscle antibodies (SMAs), rheumatoid factor (RF), anti-mitochondrial antibodies (AMAs), anti—liver and kidney microsomal (LKM) antibodies, and cryoglobulins. We found a high prevalence of positivity, particularly for anti-SMAs (66%) and RF (76%) in both men and women. Forty of 41 patients tested negative for anti-LKM antibodies. There were no significant differences in age, gender, severity of hepatitis, or response to IFN between those who were positive for autoimmune markers and those who were not. None of the patients treated with IFN developed clinical manifestations of autoimmune disease. We conclude that markers of autoimmunity occur with high and equal frequency in men and women with chronic hepatitis C. Their presence should not preclude therapy with IFN, which often improves hepatitis and features of autoimmune disease in patients with both.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa
Davis, G. L., Balart, L. A., Schiff, E. R., Lindsay, K., Bodenheimer, H. C., Perrillo, R. P., Carey, W., Jacobson, I. M., Payne, J., Dienstag, J. L., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212203 · Cited by 1,633
Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Gitnick, G. L., Elveback, L. R., & Schoenfield, L. J. (1972) · Gastroenterology · doi:10.1016/s0016-5085(19)33223-8 · Cited by 779
(1965) · Elsevier eBooks · doi:10.1016/c2013-0-06663-7 · Cited by 664
Homberg, J.-C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S. H., Poupon, R., Darnis, F., Lévy, V.-G., Grippon, P., et al. (1987) · Hepatology · doi:10.1002/hep.1840070626 · Cited by 576
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
Self-citationManns, M. P., Johnson, E. F., Griffin, K. J., Tan, E. M., & Sullivan, K. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113949 · Cited by 363
Self-citationPrescribing in General Practice
(1899) · BMJ · doi:10.1136/bmj.1.2007.1510-c · Cited by 238
Non-A, Non-B Post-Transfusion Hepatitis: Looking Back in the Second Decade
Koretz, R. L., Abbey, H., Coleman, E., & Gitnick, G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-2-199307150-00003 · Cited by 233
Cited by
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Self-citationExtrahepatic manifestations of chronic hepatitis C
Cacoub, P., Poynard, T., Ghillani, P., Charlotte, F., Olivi, M., Charles Piette, J., Opolon, P., & for the MULTIVIRC GROUP (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199910)42:10<2204::aid-anr24>3.0.co;2-d · Cited by 648
Cacoub, P., Renou, C., Rosenthal, E., Cohen, P., Loury, I., Loustaud-Ratti, V., Yamamoto, A.-M., Camproux, A.-C., Hausfater, P., Musset, L., et al. (2000) · Medicine · doi:10.1097/00005792-200001000-00005 · Cited by 565
Hasler, J. A., Estabrook, R., Murray, M., Pikuleva, I., Waterman, M., Capdevila, J., Holla, V., Helvig, C., Falck, J. R., Farrell, G., et al. (1999) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(99)00005-9 · Cited by 267
Autoimmune hepatitis and its variant syndromes
BEN-ARI, Z., & CZAJA, A. J. (2001) · Gut · doi:10.1136/gut.49.4.589 · Cited by 102
Metadata
- Authors
- Clifford, B. D., Donahue, D., Smith, L., Cable, E., Luttig, B., Manns, M., & Bonkovsky, H. L.
- Venue
- Hepatology
- Published
- 1995-03
- Volume
- 21
- Issue
- 3
- Pages
- 613-619
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2069940412
- Cited by
- 354
- References
- 28
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C†. https://app.cochat.ai/papers/10.1002/hep.1840210302
- The paper
- Clifford, B. D., Donahue, D., Smith, L., Cable, E., Luttig, B., Manns, M., & Bonkovsky, H. L. (1995). High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C†. Hepatology. https://doi.org/10.1002/hep.1840210302
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.